1. Influenza virus characterization - Summary Europe, May 2024
2 aug 2024 · This report contains genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection ...
This report contains genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 August 2023 until 31 January 2024.
2. [PDF] Influenza Vaccine Products for the 2024-2025 Influenza Season
Dosing for infants and children age 6 through 35 months: • Afluria 0.25 mL. • Fluarix 0.5 mL. • Flucelvax 0.5 mL. • FluLaval 0.5 mL. • Fluzone 0.25 mL or 0.5 mL.
3. Recommended composition of influenza virus vaccines for use in ...
29 sep 2023 · The WHO recommends that trivalent vaccines for use in the 2024 southern hemisphere influenza season contain the following:
Publications of the World Health Organization
4. Recommended composition of influenza virus vaccines for use in ...
23 feb 2024 · Recommended composition of influenza virus vaccines for use in the 2024-2025 northern hemisphere influenza season · Overview · Related links.
Publications of the World Health Organization
5. Seasonal Influenza Vaccine Supply Frequently Asked Questions - CDC
17 sep 2024 · Manufacturers project 148 million flu vaccines for 2024-2025; most will be thimerosal-free and egg-based.
Learn More about Flu Vaccine Supply and Distribution
See AlsoRolled Gold Prices Per Gram
6. Use of Trivalent Influenza Vaccines for the 2024-2025 U.S. ... - FDA
5 mrt 2024 · Influenza virus strains for a trivalent vaccine composition for use in the U.S. were recommended on March 5, 2024, by the Committee based on the ...
FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on March 5, 2024, to discuss and make recommendations on the selection of influenza viruses for the composition of influenza vaccines for the 2024-2025 U.S. influenza season.
7. Flu vaccines for the 2024 to 2025 season - GOV.UK
16 aug 2024 · Flu vaccines ; Fluenz, live attenuated influenza vaccine ( LAIV ) · AstraZeneca, licensed from 2 years to under 18 years of age ; Quadrivalent ...
8. Influenza virus characterization - Summary report, Europe, January ...
20 feb 2024 · Genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 January 2023 until 31 August ...
Genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 January 2023 until 31 August 2023 informed the WHO influenza vaccine composition meeting (VCM) in September 2023 when recommendations were made for the southern hemisphere (SH) 2024 influenza season.
9. Prevention and Control of Seasonal Influenza with Vaccines ... - CDC
29 aug 2024 · This report focuses on recommendations for the use of vaccines for the prevention and control of seasonal influenza during the 2024–25 influenza season in the ...
This report provides new CDC recommendations for the ...
10. Flu vaccination programme 2024 to 2025: information for healthcare ...
There is one egg-free vaccine available for the 2024 to 2025 flu season. This is the cell-based quadrivalent vaccine ( QIVc ) made by CSL Seqirus UK (licensed ...
11. Influenza Season 2023/2024 — 20.2 Million Doses of Flu Vaccine ...
26 sep 2023 · As of late September 2023, the Paul-Ehrlich-Institut had already released over 20 million doses of influenza vaccine.
The Paul-Ehrlich-Institut (PEI), the Federal Institute for Vaccines and Biomedicines, is once again prepared for this year's influenza vaccine demand. This year it is possible to be vaccinated with an adapted COVID-19 vaccine and the influenza vaccine at the same time and thus obtain immune protection against both viral diseases.